NO942913L - Fremgangsmåte for fremstilling av inflammatoriske dermatoser - Google Patents
Fremgangsmåte for fremstilling av inflammatoriske dermatoserInfo
- Publication number
- NO942913L NO942913L NO942913A NO942913A NO942913L NO 942913 L NO942913 L NO 942913L NO 942913 A NO942913 A NO 942913A NO 942913 A NO942913 A NO 942913A NO 942913 L NO942913 L NO 942913L
- Authority
- NO
- Norway
- Prior art keywords
- corticosteroid
- preparation
- retinoid
- treatment
- healing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Inflammatoriske dermatoser kontrolleres og helbredes ved topisk påføring på de rammede hudområder av et preparat inneholdende både et kortiko- steroid og et retinoid. Den kombinerte terapi er mer effektiv enn hver aktiv bestanddel alene og er spesielt effek- tiv mot kroniske dermatoser som er, eller har blitt, resistente mot kor- tikosteroidbehandling alene. Etter at helbredelse er oppnådd med behandling en eller to ganger daglig med kortiko- steroid-retinoidpreparatet, vanligvis etter flere uker, kan helbredelse opp- rettholdes ved mindre hyppig behand- ling, eller med lavere konsentrasjoner av preparatet, eller ved behandling med kun ett av kortikosteroidet eller retinoidet, mindre potente kortiko- steroider, eller andre ikke-steroidale terapier, avhengig av den spesielle dermatose som behandles.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US83282892A | 1992-02-07 | 1992-02-07 | |
PCT/US1993/001043 WO1993015740A1 (en) | 1992-02-07 | 1993-01-29 | Methods of treating inflammatory dermatoses |
Publications (2)
Publication Number | Publication Date |
---|---|
NO942913D0 NO942913D0 (no) | 1994-08-05 |
NO942913L true NO942913L (no) | 1994-10-05 |
Family
ID=25262717
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO942913A NO942913L (no) | 1992-02-07 | 1994-08-05 | Fremgangsmåte for fremstilling av inflammatoriske dermatoser |
Country Status (12)
Country | Link |
---|---|
US (1) | US5998395A (no) |
EP (1) | EP0625045A4 (no) |
JP (1) | JP2927961B2 (no) |
KR (1) | KR100282575B1 (no) |
AU (1) | AU667519B2 (no) |
CA (1) | CA2129114A1 (no) |
CZ (1) | CZ188394A3 (no) |
FI (1) | FI943625A (no) |
NO (1) | NO942913L (no) |
NZ (1) | NZ249379A (no) |
WO (1) | WO1993015740A1 (no) |
ZA (1) | ZA93811B (no) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994006434A1 (en) * | 1992-09-11 | 1994-03-31 | Sandra Brown | Method and composition for the treatment of hair loss |
US6344448B1 (en) | 1992-09-11 | 2002-02-05 | Stb Family Limited Partnership | Composition for the treatment of hair loss |
US7115728B1 (en) | 1995-01-30 | 2006-10-03 | Ligand Pharmaceutical Incorporated | Human peroxisome proliferator activated receptor γ |
AU5728596A (en) * | 1995-05-05 | 1996-11-21 | Mark S. Braiman | Treatment of psoriasis with 11-cis-retinoic acid |
US6008254A (en) | 1997-05-09 | 1999-12-28 | Kligman; Douglas E. | Method of treating skin disorders with high-strength tretinoin |
WO1999005161A1 (en) | 1997-07-25 | 1999-02-04 | Ligand Pharmaceuticals Incorporated | HUMAN PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA (PPARη) GENE REGULATORY SEQUENCES AND USES THEREFOR |
US8541469B2 (en) * | 1997-08-23 | 2013-09-24 | Glaxo Group Limited | Treatment of cell-mediated immune diseases |
US6355669B1 (en) * | 1997-10-22 | 2002-03-12 | Eisai Co., Ltd. | Retinoic acid agonists as preventive and therapeutic agents for nephritis |
FR2761600B1 (fr) | 1998-06-19 | 2000-03-31 | Oreal | Composition moussante pour le lavage et le traitement des cheveux et/ou du cuir chevelu a base d'un principe actif, d'un tensioactif anionique, d'un tensioactif amphotere et d'un agent propenetrant |
US6242473B1 (en) * | 1999-01-08 | 2001-06-05 | Maxim Pharmaceuticals, Inc. | Treatment and prevention of reactive oxygen metabolite-mediated cellular damage |
FR2804323B1 (fr) | 2000-01-31 | 2006-07-07 | Galderma Res & Dev | Utilisation de composes de type retinoides en tant qu'agents anti-bacteriens |
US20050003023A1 (en) * | 2002-06-28 | 2005-01-06 | Meisner Lorraine Faxon | Topical composition for the treatment of psoriasis and related skin disorders |
US6440465B1 (en) * | 2000-05-01 | 2002-08-27 | Bioderm, Inc. | Topical composition for the treatment of psoriasis and related skin disorders |
WO2001085156A1 (fr) * | 2000-05-09 | 2001-11-15 | Kaneka Corporation | Compositions dermiques ayant la coenzyme q comme principe actif |
US6713515B2 (en) | 2000-09-13 | 2004-03-30 | Bristol Myers Squibb Company | Retinoic acid receptor antagonists as promoters of angiogenesis |
KR20020027198A (ko) * | 2000-10-02 | 2002-04-13 | 차알스 제이. 메츠 | 염증과 홍반의 완화방법 |
FR2823117A1 (fr) * | 2000-11-14 | 2002-10-11 | Pharmascience Lab | Composition pharmaceutique ou cosmetique ainsi que l'utilisation d'au moins un compose actif pour inhiber la migration des cellules de langerhans |
US20020146744A1 (en) * | 2001-03-02 | 2002-10-10 | Lawandy Nabil M. | Combinatorial chemistry and compound identification system |
ES2188426B1 (es) * | 2001-12-12 | 2004-11-16 | Rosalia Pidal Fernandez | Composicion farmaceutica para el tratamiento de la psoriasis y otras dermopatias. |
US20030199488A1 (en) * | 2002-04-23 | 2003-10-23 | Trotta Gina M. | Treatment of hyperproliferative disorders/inflammatory dermatoses |
US6723755B2 (en) | 2002-06-12 | 2004-04-20 | Piotr Chomczynski | Method of treating rosacea |
US20040171561A1 (en) * | 2002-09-03 | 2004-09-02 | Popp Karl F. | Topical formulations for treatment of rosacea |
WO2004037197A2 (en) * | 2002-10-24 | 2004-05-06 | Goldstein Jay A | Antifungal formulations |
US20050095215A1 (en) * | 2003-11-03 | 2005-05-05 | Popp Karl F. | Antimicrobial shampoo compositions |
BRPI0416812A (pt) * | 2003-11-21 | 2007-03-06 | Combinatorx Inc | métodos e reagentes para o tratamento de desordens inflamatórias |
JP2007523156A (ja) * | 2004-02-19 | 2007-08-16 | ケマファー インコーポレイティッド | 皮膚状態の処置用の局所製剤 |
US7812057B2 (en) * | 2004-08-25 | 2010-10-12 | Molecular Research Center, Inc. | Cosmetic compositions |
NZ554476A (en) | 2004-09-28 | 2010-09-30 | Chemaphor Inc | Compositions and methods for promoting weight gain feed conversion |
US20070009607A1 (en) * | 2005-07-11 | 2007-01-11 | George Jones | Antibacterial/anti-infalmmatory composition and method |
CA2704098C (en) | 2007-10-26 | 2018-01-02 | Chemaphor Inc. | Compositions and methods for enhancing immune response |
ES2327201B1 (es) | 2008-04-23 | 2010-07-23 | Ignacio Umbert Millet | Composicion farmaceutica personalizada para el rejuvenecimiento de la piel que contiene acido retinoico. |
EP2424512B1 (en) | 2009-04-30 | 2020-06-03 | Avivagen Inc. | Methods and compositions for improving the health of animals |
KR101791277B1 (ko) | 2009-10-20 | 2017-10-27 | 디스커버리 파트너스, 엘엘씨 | 피부과학 및 미용학적 조성물 |
ES2378028B1 (es) | 2012-02-22 | 2013-02-18 | Ignacio Umbert Millet | Composición cosmética para el rejuvenecimiento de la piel y procedimiento y usos correspondientes |
CA3077331A1 (en) * | 2017-09-28 | 2019-04-04 | Johnson & Johnson Consumer Inc. | Cosmetic compositions and method of treating the skin |
RU2712281C1 (ru) * | 2018-11-23 | 2020-01-28 | Общество С Ограниченной Ответственностью "Хемиммьюн Терапьютикс" | Применение производного глутаримида для преодоления резистентности к стероидам и терапии заболеваний, ассоциированных с аберрантным сигналингом интерферона гамма |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3729568A (en) * | 1969-09-23 | 1973-04-24 | Johnson & Johnson | Acne treatment |
US4126693A (en) * | 1975-11-03 | 1978-11-21 | Johnson & Johnson | Retinoic acid derivatives in the treatment of acne |
ZA77678B (en) * | 1977-02-07 | 1978-09-27 | S Fourie | Pharmaceutical composition and use thereof |
US4487782A (en) * | 1982-03-26 | 1984-12-11 | Ortho Pharmaceutical Corporation | Topical treatment of non-inflammatory acne |
US4889847A (en) * | 1986-11-03 | 1989-12-26 | Ortho Pharmaceutical Corporation | Prevention of glucocorticoid-induced skin atrophy |
US5019569A (en) * | 1986-11-03 | 1991-05-28 | Ortho Pharmaceutical Corporation | Reversal of glucocorticoid-induced skin atrophy |
-
1993
- 1993-01-29 NZ NZ249379A patent/NZ249379A/en not_active IP Right Cessation
- 1993-01-29 CZ CZ941883A patent/CZ188394A3/cs unknown
- 1993-01-29 WO PCT/US1993/001043 patent/WO1993015740A1/en not_active Application Discontinuation
- 1993-01-29 EP EP93904929A patent/EP0625045A4/en not_active Withdrawn
- 1993-01-29 CA CA002129114A patent/CA2129114A1/en not_active Abandoned
- 1993-01-29 JP JP5514192A patent/JP2927961B2/ja not_active Expired - Lifetime
- 1993-01-29 KR KR1019940702690A patent/KR100282575B1/ko not_active IP Right Cessation
- 1993-01-29 AU AU35854/93A patent/AU667519B2/en not_active Ceased
- 1993-02-05 ZA ZA93811A patent/ZA93811B/xx unknown
- 1993-09-10 US US08/119,510 patent/US5998395A/en not_active Expired - Fee Related
-
1994
- 1994-08-04 FI FI943625A patent/FI943625A/fi unknown
- 1994-08-05 NO NO942913A patent/NO942913L/no unknown
Also Published As
Publication number | Publication date |
---|---|
CZ188394A3 (en) | 1996-02-14 |
EP0625045A4 (en) | 1995-01-18 |
KR100282575B1 (ko) | 2001-02-15 |
FI943625A0 (fi) | 1994-08-04 |
KR950700069A (ko) | 1995-01-16 |
JPH07505617A (ja) | 1995-06-22 |
NO942913D0 (no) | 1994-08-05 |
WO1993015740A1 (en) | 1993-08-19 |
AU667519B2 (en) | 1996-03-28 |
CA2129114A1 (en) | 1993-08-19 |
AU3585493A (en) | 1993-09-03 |
ZA93811B (en) | 1993-09-10 |
EP0625045A1 (en) | 1994-11-23 |
US5998395A (en) | 1999-12-07 |
JP2927961B2 (ja) | 1999-07-28 |
NZ249379A (en) | 1998-07-28 |
FI943625A (fi) | 1994-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO942913L (no) | Fremgangsmåte for fremstilling av inflammatoriske dermatoser | |
DK0682514T3 (da) | Anvendelse af lokalanæstetiske midler til fremstilling af et lægmiddel til behandling af bronchial astma | |
NO20050204L (no) | Kombinasjoner av legemidler for behandling av neoplasmer | |
DK0719145T3 (da) | Nitrogenoxiddonorpræparat til behandling af anale lidelser | |
DE69829112D1 (de) | Butyrate derivaten zur behandlung von fibromyalgia und chronische müdigkeit-syndrom | |
DE69433079D1 (de) | Verwendung von imidazole zur behandlung von krankheiten, die durch neovaskularisierung gekennzeichnet sind | |
BR0213100A (pt) | Combinações para o tratamento de distúrbios imuniinflamatórios | |
ATE421877T1 (de) | Verwendung von totarol zur behandlung von pruritus | |
ATE173622T1 (de) | Verwendung von cineol oder menthol zur behandlung von asthma | |
DE69519582D1 (de) | Kontrolle des haarwuchses | |
ATE151977T1 (de) | Therapeutisch wirksame, örtliche anwendung von st1435 | |
ES2139674T3 (es) | Metodo para tratar la sintomatologia del sindrome premenstrual con vitamina d o vitamina d y calcio. | |
WO2023019095A3 (en) | Momelotinib combination therapy | |
ATE206052T1 (de) | Verwendung von sphingosin-1-phosphat, sphingosin- 1-phosphat-derivaten und/oder deren gemische zur behandlung von entzündlichen hautkrankheiten | |
NO961589L (no) | Farmasöytiske blandinger | |
NO982935L (no) | Hyaluronsyre reseptor bindemiddel og anvendelse derav | |
RU2230549C2 (ru) | Способ лечения аллергических дерматозов | |
ATE240110T1 (de) | Verwendung von natriumchlorid zur behandlung der akne und/oder der rosacea | |
Rosted | Treatment of skin diseases with acupuncture a review | |
BR0012121A (pt) | Derivado de aminotetralina para terapia de doenças cardiovasculares | |
RU2696532C2 (ru) | Способ моделирования лимфовенозной недостаточности в тазовых органах | |
DK0659079T3 (da) | Transdermalt terapeutisk system med pentylentetrazol som aktivt stof. | |
RU2067010C1 (ru) | Способ лечения трофических язв | |
JPH02142734A (ja) | プロポリス併用皮膚病治療方法 | |
MOHIUDDIN | Menerganj Dispensary, District Purnea, Bihar |